BIA
CL icon

Benchmark Investment Advisors’s Colgate-Palmolive CL Stock Holding History

Benchmark Investment Advisors’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-5,078
Closed -$433K – 152
2021
Q4 		$433K Buy
+5,078
New +$397K 0.36% 73

Other funds holding CL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Benchmark Investment Advisors's CL Position: Q1 2022 in Review

Benchmark Investment Advisors sold out of Colgate-Palmolive (CL) in Q1 2022, closing a stake of 5,078 shares — an estimated $433K sold.

Benchmark Investment Advisors first reported a position in CL in Q4 2021 and held it in 1 quarter. The position peaked at $433K in Q4 2021. 1,633 funds tracked by Wall St. Rank hold CL as of Q1 2022.

  • Benchmark Investment Advisors reported no remaining Colgate-Palmolive position as of Q1 2022 after selling out during the quarter.
  • Benchmark Investment Advisors sold 5,078 Colgate-Palmolive shares in Q1 2022, an estimated $433K.
  • Benchmark Investment Advisors first reported a position in Colgate-Palmolive in Q4 2021 and held it in 1 quarter.
  • Benchmark Investment Advisors's Colgate-Palmolive position peaked at $433K in Q4 2021.
  • 1,633 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2022.

Based on Benchmark Investment Advisors's 13F filing for Q1 2022, filed 16 May 2022.